NFKB1 and neoplasm: More recent studies, carried out in two independent cohorts comprising nearly 700 glioblastoma patients, revealed that patients with high miR-181 expression levels had longer overall survival and that these miRNAs may act as a tumor suppressor by targeting the NF-κB and EMT pathways.